AstraZeneca PLCAZN:NYQ

71.55
0.54 / 0.76%
610.20k
12.75%
0.5667
Real-time price in USDToday's changeShares traded1 year changeBeta
As of Jan 29 2015 16:20 GMT. BATS BZX Real-Time Last Sale

Summary

As of last trade, AstraZeneca PLC (AZN:NYQ) traded at 71.55, 15.87% above the 52 week low of 61.75 set on Feb 06, 2014.

52-week range
Today
61.75
Feb 06 2014
82.68
May 01 2014
Markit short selling activity
Low
Medium
High
Open72.12
Day high72.21
Day low71.39
Bid71.54
Offer71.56
Previous close71.01
Average volume2.07m
Shares outstanding1.26bn
Free float1.24bn
P/E (TTM)88.48
Market cap89.99bn USD
EPS (TTM)0.8125 USD
Annual div (TTM)2.80 USD
Annual div yield (TTM)3.94%
Div ex-dateAug 13 2014
Div pay-dateSep 15 2014
As of Jan 29 2015 16:20 GMT.BATS BZX Real-Time Quote

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
AstraZeneca PLC+1.13%+0.95%-1.87%+12.56%+53.65%
S&P 500 INDEX-2.96%-4.23%+3.70%+12.85%+86.44%
Data delayed at least 15 minutes, as of Jan 29 2015 16:05 GMT.
© Thomson Reuters Click for restrictions.

Real-time data provided by BATS.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.